Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Updated Direct-to-Consumer Awareness Campaign Available for LINZESS

Written by: | andrew.humphreys@medadnews.com | Dated: Wednesday, April 15th, 2015

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. announced today the launch of an updated direct-to-consumer (DTC) awareness campaign for LINZESS® (linaclotide).

Please see full Prescribing Information including Boxed Warning at http://www.frx.com/pi/linzess_pi.pdfThe company has made the television advertisement available on Business Wire’s website and YouTube channel. More information about LINZESS is available at www.linzess.com.

LINZESS® is a trademark owned by Ironwood Pharmaceuticals, Inc. Any other trademarks referred to in this alert are the property of their respective owners. All rights reserved.

Contacts

Ironwood Pharmaceuticals, Inc.
Media Relations:
Trista Morrison, 617374-5095
tmorrison@ironwoodpharma.com
or
Investor Relations:
Meredith Kaya, 617-374-5082
mkaya@ironwoodpharma.com

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!

Subscribe

Ad Right Bottom